Kaspar supports Alithea Genomics SA with his vast biotech company building experience.
Kaspar is founder and CEO of Binz Biotech Consulting GmbH, a company supporting biotech companies in their growths. He is also co-founder and chairman of the board of directors of arcoris bio AG, a company providing next-generation multiplex biomolecule detection technology.
Kaspar co-founded Molecular Partners AG (SIX/NASDAQ: MOLN), a Swiss clinical stage biotech company developing DARPin® drugs for therapeutic applications, where he acted in various positions from 2004 to 2019 including VP, CSO, and member of the board of directors.
Kaspar enjoys supporting the Swiss biotech startup environment by engagement in various juries and evaluation committees.